sulotroban has been researched along with Blood Clot in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Müller-Beckmann, B; Patscheke, H; Pill, J; Schmidt, FH; Stegmeier, K; Witte, EC; Wolff, HP | 1 |
| Berridge, DC; Heptinstall, S; Hopkinson, BR; Lonsdale, RJ; Makin, GS; Wenham, PW; Westby, JC | 1 |
| Barbenel, JC; Forbes, CD; Lowe, GD; Madhok, R; Saniabadi, AR; Shaw, B; Spowart, K | 1 |
| Fujita, T; Hasan, S; Shebuski, RJ; Storer, BL | 1 |
1 trial(s) available for sulotroban and Blood Clot
| Article | Year |
|---|---|
A study of the use of the thromboxane A2 antagonist, sulotroban, in combination with streptokinase for local thrombolysis in patients with recent peripheral arterial occlusions: clinical effects, platelet function and fibrinolytic parameters.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blood Platelets; Drug Therapy, Combination; Female; Fibrinolysis; Fibrinolytic Agents; Humans; Ischemia; Leg; Male; Middle Aged; Platelet Aggregation; Serotonin; Streptokinase; Sulfonamides; Thrombosis | 1993 |
3 other study(ies) available for sulotroban and Blood Clot
| Article | Year |
|---|---|
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Epoprostenol; Female; Fibrinolytic Agents; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Rabbits; Sulfonamides; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
Red blood cells mediate spontaneous aggregation of platelets in whole blood.
Topics: 2-Chloroadenosine; Adenosine; Adult; Aged; Aspirin; Epoprostenol; Erythrocytes; Humans; Iloprost; In Vitro Techniques; Middle Aged; Platelet Aggregation; Platelet Count; Sulfonamides; Thrombosis | 1987 |
Effect of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on tPA-induced thrombolysis in a rabbit model of femoral arterial thrombosis.
Topics: Animals; Femoral Artery; Fibrinolytic Agents; In Vitro Techniques; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Recombinant Proteins; Regional Blood Flow; Sulfonamides; Thrombosis; Thromboxane A2; Tissue Plasminogen Activator | 1989 |